Brought to you by 
Procept, Pacific Pharmaceuticals combine
13 Jul 1999
Executive Summary
Pacific Pharmaceuticals (manages development cancer drugs from the preclinical stage) has agreed to merge into Procept (developing anti-infectives and immunosuppressants).
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Payment Includes Stock
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Procept, Pacific Pharmaceuticals combine
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice